1) Tsukuma H, Hiyama T, Tanaka S, et al: Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328:1797-1801,1993
2) Tsubota A, Chayama K, Ikeda K, et al: Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 19:1088-1094,1994
3) Simmonds P, Holmes EC, Cha TA, et al: Classification of hepatitis C virus into six major genotypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391-2399,1993
4) Okamoto H, Sugiyama Y, Okada S, el al: Typing hepatitis C virus by polymerase chain reaction with type specific primers-application to clinical surveys and tracing infectious sources. J. gen virol 73:673-679,1992
5) Chayama K, Tsubota A, Arase Y, et al: Genotypic subtyping of hepatitis C virus. J Gastroenterol Hepatol 8:150-156,1993
6) Tsukiyama-kohara K, Yamaguchi K, Maki N, et al: Antigenicities of group I and group II hepatitis C virus polypeptides molecular basis of diagnosis. Virology 192:430-437,1993
7) Germer JJ, Rys PN, Thorvilson JN, et al: Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. J Clin Microbiol 37:2625-2630,1999
8) Gargiulo F, De Francesco MA, Pinsi G, et al: Determination of HCV genotype by direct sequence analysis of Quantitative PCR products. J Med Virol 69:202-206,2003
9) Chen Z, Weck KE: Hepatitis C virus genotyping: Interrogation of the 5'untranslated region cannot accuracy distinguish genotypes 1a and 1b. J Clin Microbiol 40:3127-3134,2002